ALFA Finder| Value | ₹1,200 Cr |
|---|
NSE filing, NSE: MAXESTATES. Summary written from the filing by ALFA Finder's alert engine.
Max Estates Ltd: key numbers
- Share price
- ₹502.45
- Market cap
- ₹8,219 Cr
- Revenue (annual)
- ₹199.4 Cr
- Net profit (annual)
- ₹12.51 Cr
- P/E (TTM)
- 915.4×Sector 38.2×
- Promoter holding
- 45.23%-0.03% QoQ
- FII holding
- 26.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Estates Ltd
All →Max Estates Earnings Call Transcript: Key Takeaways
Strong Q2 pre-sales (₹2,100 Cr, 274 units) but thin reported P&L: revenue ₹52.5 Cr, PAT ₹4.7 Cr, pending handovers.
Max Estates Investor Presentation: Key Takeaways
Q2 FY27 pre-sales ₹2,092 Cr (~14x YoY); H1 FY27 pre-sales ₹3,184 Cr, collections ₹1,051 Cr. Reported P&L is small (FY26 revenue ₹199.4 Cr, PBT ₹23.3 Cr); ₹4,800–5,700 Cr embedded PBT to be recognised FY28–FY31.
Max Estates Results Update
Max Estates reported H1 FY27 pre-sales of INR 3,200 crore and Q2 PAT of INR 4.7 crore. It also signed an MOU for a Delhi land acquisition.
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Max Estates Debt & Borrowing: ₹350 Cr
Max Estates' board approved a ₹350 crore corporate guarantee for a wholly-owned subsidiary's term loan. Monitoring agency reports on its QIP and warrant proceeds were also filed.
- Value
- ₹350.0 Cr
Max Estates Q2 FY27 Results: Net Profit ₹4.7 Cr, Down 39.7% YoY
Max Estates Ltd reported revenue from operations of ₹52.8 Cr (+8.2% YoY) and net profit of ₹4.7 Cr (-39.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.7 Cr · -39.7% YoY
Other product launch announcements
All →AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum
Restaurant Brands Asia Product Launch
Burger King India launches a limited-edition Avengers: Doomsday Collection across nationwide restaurants. The menu features themed burgers, sides, and merchandise starting at ₹199.
Hero MotoCorp Product Launch
Hero MotoCorp unveiled new motorcycles at EICMA 2026 and started VIDA customer deliveries across Europe. The company also introduced Novus Labs, its future-mobility innovation hub.